Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Roche Holding AG banner

Roche Holding AG
SWB:RHO

Watchlist Manager
Roche Holding AG Logo
Roche Holding AG
SWB:RHO
Watchlist
Price: 245 EUR Market Closed
Market Cap: €198.3B
Write Note Create Alert

Intrinsic Value

Is RHO undervalued or overvalued?

See the intrinsic value estimate for Roche Holding AG and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

RHO Intrinsic Value
LOCKED
Unlock
Today vs. history

RHO looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with RHO’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor RHO
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €245
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RHO

Fundamental Analysis

What Roche Does

Pharmaceuticals Health Care

Roche Holding AG is a Swiss healthcare company that makes prescription medicines and diagnostic tests. Its drug business focuses on treatments in cancer, immunology, ophthalmology, and other serious diseases, while its diagnostics business sells instruments, lab tests, and software that help hospitals and laboratories detect disease and monitor patients. In simple terms, Roche helps doctors find illnesses and choose treatments, and it earns money by selling these medicines, test kits, and related systems to healthcare providers and distributors.

Headquarters
Switzerland CH
Employees
100 920
IPO date
May 4, 2001
Read the full company overview
View Company Overview

Roche Holding has no economic moat

No Moat Narrow Wide

Roche’s patents protect individual medicines for a time, but lower-priced copies and rival treatments can compete for customers when those protections end or another option is preferred. Patients and prescribers are not tied to Roche’s wider portfolio, and use of its medicines does not make them more valuable simply because more people use them; competitors can challenge Roche product by product.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Roche Holding AG

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Continue RHO Research

Summary
RHO intrinsic value, competitors valuation, and company profile.
DCF Valuation
RHO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RHO stock valuation using valuation multiples.
Wall St Estimates
RHO price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RHO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Roche Holding AG listings:
OTC • USD
RHHBF
 OTC • USD
RHHBY
 OTC • USD
RHHVF
 LSE • CHF
0QQ6
 F • EUR
RHO
 F • EUR
RHO6
 SIX • CHF
RO
 SWB • EUR
RHO6
 DUS • EUR
RHO
 LSE • USD
0TDF
 MIL • EUR
1RO
 XMUN • EUR
RHO
 XETRA • EUR
RHO
Discover More
What is the Intrinsic Value of one RHO stock?

The intrinsic value for Roche Holding AG (RHO) under the Base Case is hidden EUR.

Is RHO stock undervalued or overvalued?

Compared with the current market price of 245 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.